Rapid Oncological Diagnosis of Lung Cancer: Specific Facility Experience

Introduction: In order to improve diagnosis procedure by public health service, an organizational solution called Rapid Oncological Therapy has been introduced. The introduction of this program caused criticism of the medical community, and state control authorities showed irregularities in its functioning in medical clinics. Its aim was to assess this process among lung cancer patients hospitalized in the Clinic for 9 months. Material and methods: After the analysis of imaging tests, the patients were qualified for invasive tests (bronchoscopy, EBUS). Patients with histopathological diagnosis of NSCLC were subjected to molecular diagnostics. After completing the diagnosis and establishing the final diagnosis, the patient's forfeiture was presented at the clinical meeting. Results: The analysis involved 209 patients who had a DILO card issued. 156 patients were diagnosed with lung cancer and qualified for the consulate. Among the histopathological types, NSCLC dominated—80%. SCLC was 17% of the types. By the decision made on medical case conference, 135 patients have been qualified for casual treatment, among others 12% surgical treatment; 47% chemotherapy, 18% radiotherapy; 8% chemo-radiotherapy. An average waiting time for diagnosis process to begin, after DILO card has been issued was 16.33 (±18.78) days, an average hospitalization and diagnosis time was 9.16 (±6.61) days. Around 31.3 (±14.93) days on average have passed from the start of diagnostical hospitalization until beginning of the causal treatment. Conclusions: In a multi-specialist center, it is possible to develop a care model for lung cancer patients, consistent with Rapid Oncological Diagnosis.